Package 45802-147-62

{"route": ["ORAL"], "spl_id": "1e179f00-1e00-4199-bf78-bb00aa268c74", "openfda": {"unii": ["64O047KTOA", "6V9V2RYJ8N"], "rxcui": ["1014571"], "spl_set_id": ["3260111b-35da-4f95-8081-51eae4b1ef45"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BLISTER PACK in 1 CARTON (45802-147-53)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "45802-147-53", "marketing_start_date": "20200331"}, {"sample": false, "description": "24 BLISTER PACK in 1 CARTON (45802-147-62)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "45802-147-62", "marketing_start_date": "20200331"}], "brand_name": "Cetirizine hydrochloride and Pseudoephedrine hydrochloride", "product_id": "45802-147_1e179f00-1e00-4199-bf78-bb00aa268c74", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "45802-147", "generic_name": "Cetirizine hydrochloride, Pseudoephedrine hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Cetirizine hydrochloride and Pseudoephedrine hydrochloride", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA210719", "marketing_category": "ANDA", "marketing_start_date": "20200331", "listing_expiration_date": "20261231"}